Compound 861
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1cccc(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1
- IUPAC name:
4-[4-[2-[3-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenyl]ethoxy]phenyl]benzoic acid
- InChi:
InChI=1S/C33H35NO4/c1-34(2)22-7-21-33(37,29-9-4-3-5-10-29)30-11-6-8-25(24-30)20-23-38-31-18-16-27(17-19-31)26-12-14-28(15-13-26)32(35)36/h3-6,8-19,24,37H,7,20-23H2,1-2H3,(H,35,36)/t33-/m0/s1
- InChiKey:
LZQAWDUSDZHIAS-XIFFEERXSA-N
External links
168318054 |
26363799 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.47 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 509.26 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.80 | |||
TPSA | 70.00 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6140 | Ansofaxine | DB15052 | |
0.5917 | Darifenacin | DB00496 | |
0.5652 | Fesoterodine | DB06702 | |
0.5588 | Fexofenadine | DB00950 | |
0.5514 | Adapalene | DB00210 | |
0.5441 | Adomeglivant | DB11704 | |
0.5429 | (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid | DB08121 | |
0.5391 | {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DB07237 | |
0.5385 | Lifibrol | DB12448 | |
0.5370 | Dyclonine | DB00645 | |
0.5338 | 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid | DB04405 | |
0.5204 | Terfenadine | DB00342 | |
0.5155 | Diphenidol | DB01231 | |
0.5128 | LY-2300559 | DB13016 | |
0.5079 | Etripamil | DB12605 |